TREC as a personalized tuberculosis predictor in infants and preschool children
-
Published:2023-01-17
Issue:4
Volume:
Page:54-57
-
ISSN:1609-1175
-
Container-title:Pacific Medical Journal
-
language:
-
Short-container-title:Tihookeanskij medicinskij žurnal
Author:
Smerdin S. V.1, Plekhanova M. A.1ORCID, Kalinina O. A.2, Ludanny R. I.1, Lazebny S. V.1, Filippov P. N.1, Kazakov A. V.3, Kudlay D. A.4, Pahlavonova A. D.3
Affiliation:
1. Moscow regional clinical tuberculosis dispensary 2. Malakhovsky children’s tuberculosis sanatorium 3. National medical research center for phthisiopulmonology and infectious diseases 4. I.M. Sechenov First Moscow State Medical University (Sechenov University); National Research Center – Institute of Immunology of Federal Medical-Biological Agency (Institute of Immunology of FMBA)
Abstract
Aim. Quantitative assessment of TREC and KREC in infants and preschool children infected with tuberculosis infection (TI). Material and methods. A prospective cross-sectional study was conducted in 2022. The observation group consisted of 87 children of early childhood age in contact with TB patients, of whom 27 were diagnosed with TB, 34 were tested positive to TB based on skin tests without signs of a local specific process (TI), 26 were children without signs of tuberculosis infection according to the results of skin tests and local process (conditionally healthy children).Results. The following factors significant in the assessment of tuberculosis infection were determined: anti-tuberculosis therapy (F = 42.001; p = 0.000001); positive or negative response to the tuberculosis recombinant allergen (RTA) during an intradermal test (F = 39.394; p = 0.000001); high TREC levels in the blood (F = 12.707; p = 0.000001); the presence of a tuberculin response (F = 10.625; p = 0.000006); and KREC levels (F = 3.182; p = 0.039). Conclusions. According to the obtained results, TREC levels can be considered as a personalized risk predictor of tuberculosis infection in infants and preschool children.
Publisher
Pacific State Medical University
Reference14 articles.
1. Delbridge LM, O’Riordan MX. Innate recognition of intracellular bacteria. Curr. Opin. Immunol. 2007;19(1):10–6. doi: 10.1016/j.coi.2006.11.005 2. van den Bergl TK, Yoder JA, Litman GW. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol. 2004;25(1):11–6. doi: 10.1016/j.it.2003.11.006 3. Drain PK, Bajema KL, Dowdy D, Dheda K, Naidoo K, Schumacher SG, Ma S, Meermeier E, Lewinsohn DM, Sherman DR. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev. 2018;31(4):e00021-18. doi: 10.1128/CMR.00021-18 4. Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Muñoz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger JP, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020;26(12):1941–9. doi: 10.1038/s41591-020-1076-0 5. Plekhanova MA, Tkachuk AP, Patsula UI, Smerdin SV. Polymorphic variant of the IFNG-gene and the level of antigen-specific production of interferon-γ in children. Pacific Medical Journal. 2021;1:28–33 (In Russ.)]. doi: 10.34215/1609-1175-2021-1-28-33
|
|